Skip to main content
SPRC
NASDAQ Life Sciences

SciSparc Receives Nasdaq Non-Compliance Notice for Minimum Stockholders' Equity

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.45
Mkt Cap
$4.769M
52W Low
$1.25
52W High
$19.089
52W Position info
16% above low
Off High info
92% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

SPRC sits 16% above its 52-week low of $1.25 on light trading volume (0.1× avg).

Summary

SciSparc Ltd. received a Nasdaq notification for non-compliance with minimum stockholders' equity, indicating financial distress, though the company expects to regain compliance through recent financing.


Key Events · Corporate Governance and Compliance · SPRC

  • Nasdaq Non-Compliance Notification

    SciSparc Ltd. received a notification from Nasdaq for failing to meet the minimum $2.5 million stockholders' equity requirement, reporting approximately $(81,000) as of June 30, 2025.

  • Compliance Plan Deadline

    The company has 45 calendar days, until February 26, 2026, to submit a plan to regain compliance with Nasdaq's listing rules.

  • Expected Resolution

    SciSparc anticipates regaining compliance by December 31, 2025, citing proceeds from a $4.2 million debenture conversion in August 2025 and a registered direct offering in November 2025.


Analysis · SPRC · Life Sciences

SciSparc Ltd. has received a notification from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement, reporting a negative equity balance of approximately $(81,000) as of June 30, 2025, significantly below the $2.5 million threshold. This notice highlights severe financial distress and poses a material risk to the company's Nasdaq listing if not resolved. While the company expects to regain compliance by December 31, 2025, through recent financing activities, investors should closely monitor the situation as failure to meet Nasdaq's requirements could lead to delisting.

At the time of this filing, SPRC was trading at $1.45 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.8M. The 52-week trading range was $1.25 to $19.09. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SPRC - Latest Insights

SPRC
Jul 15, 2026, 8:41 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.66
Real-time Price: $5.06 info
Change: +$0.4008 (+9%) info
Market Cap: $3.055M info
SPRC
Jun 22, 2026, 1:46 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $6.93
Real-time Price: $5.06 info
Change: -$1.87 (-27%) info
Market Cap: $3.055M info
SPRC
Jun 03, 2026, 5:15 PM EDT
Source: TheNewswire
Importance Score:
7
Price at Filing: $9.45
Real-time Price: $5.06 info
Change: -$4.39 (-46%) info
Market Cap: $3.055M info
SPRC
May 29, 2026, 7:40 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $9.24
Real-time Price: $5.06 info
Change: -$4.18 (-45%) info
Market Cap: $3.055M info
SPRC
May 28, 2026, 8:40 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $4.54
Real-time Price: $5.06 info
Change: +$0.5208 (+11%) info
Market Cap: $3.055M info